Mighty Therapeutics Holdings Inc - Company Profile
Powered by 
All the sales intelligence you need on Mighty Therapeutics Holdings Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Mighty Therapeutics Holdings Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Mighty Therapeutics Holdings Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Mighty Therapeutics Holdings Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Mighty Therapeutics Holdings Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Reenie McCarthy
Director; Chief Executive Officer Executive BoardMs. Reenie McCarthy has been the Chief Executive Officer and Director of the company since 2015. She has more than 20 years of experience working with private nonclinical and clinical-stage companies developing drugs across a broad spectrum of therapeutic areas.
David A. Brown, PhD
Chief Scientific Officer Senior ManagementMr. David A. Brown has been the Chief Scientific Officer of the company since April 2026. Previously, he was the Senior Vice President of Discovery of the company.
Brian Blakey
Chief Business Officer Senior ManagementMr. Brian Blakey has been the Chief Business Officer of the company since 2014. Prior to this, he served as the Chief Operating Officer of Element Marketing Group and Vice President of Commercial Development at Salutria. Mr. Blakey also held several positions at various leading pharmaceutical companies, including GlaxoSmithKline.
Jim Carr
Chief Clinical Development Officer Senior ManagementMr. Jim Carr has been the Chief Clinical Development Officer of the company since 2017. Prior to this, he served as the Executive Director in the Global Cardiovascular Franchise at GlaxoSmithKline. Previously, he served as the Vice President of Clinical Development at Arca Biopharma. He has more than 20 years of industry experience in the areas of clinical development, medical affairs, lifecycle management, new product planning, and global marketing.
Henry Hess
Chief Legal Counsel Senior ManagementMr. Henry Hess is the Chief Legal Counsel of the company. Prior to this, he served as an Attorney with the law firms of Jenner & Block and Tabet DiVito & Rothstein. Mr. Hess has more than 15 years of experience in providing business, transactional, and legal advice to both public and private life science, healthcare, and technology companies.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer